|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| C12N 15/13 | |||
| A61K 39/395 | |||
| A61P 29/00 | |||
| A61P 37/06 |
| (11) | Number of the document | 2222706 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08861706.3 |
| Date of filing the European patent application | 2008-12-15 | |
| (97) | Date of publication of the European application | 2010-09-01 |
| (45) | Date of publication and mention of the grant of the patent | 2014-04-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2008/067499 |
| Date | 2008-12-15 |
| (87) | Number | WO 2009/077483 |
| Date | 2009-06-25 |
| (30) | Number | Date | Country code |
| PCT/EP2007/0639 | 2007-12-14 | WO | |
| 08163163 | 2008-08-28 | EP |
| (72) |
URS , Birgitte, DK
WAGTMANN, Peter Andreas Nicolai Reumert, DK
PEDERSEN, Inger Lund, DK
SVENSSON, Anders, SE
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | ANTIBODIES AGAINST HUMAN NKG2D AND USES THEREOF |
| ANTIBODIES AGAINST HUMAN NKG2D AND USES THEREOF |